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A minitransposon mutant of Salmonella enterica serovar Typhimurium SR-11, SR-11 Fad2, is unable to
utilize gluconeogenic substrates as carbon sources and is avirulent and immunogenic when administered
perorally to BALB/c mice (M. J. Utley et al., FEMS Microbiol. Lett., 163:129–134, 1998). Here, evidence is
presented that the mutation in SR-11 Fad2 that renders the strain avirulent is in the cra gene, which encodes
the Cra protein, a regulator of central carbon metabolism.
Since Salmonella enterica serovar Typhimurium is able to
utilize phosphatidylserine as the sole source of carbon, nitro-
gen, and phosphate for growth (11) and since phosphatidylser-
ine is a component of eucaryotic cell membranes, it was of
interest to determine whether mutants unable to utilize either
the glycerophosphate portion or the fatty acid portion of the
phospholipid for growth are attenuated. Several mutants un-
able to utilize oleate as a sole carbon source were isolated after
mini-Tn10::d cam transposon mutagenesis (6), and one of
them, designated serovar Typhimurium SR-11 Fad2 (fatty
acid), was totally avirulent and immunogenic in BALB/c mice
when administered perorally (21). In addition, SR-11 Fad2
was found in the liver and spleen in numbers 4 to 5 orders of
magnitude lower than SR-11 (21). SR-11 Fad2 was also less
virulent than SR-11 when administered to mice intraperitone-
ally (21). Furthermore, SR-11 Fad2, in addition to being un-
able to grow utilizing oleate as a sole carbon source, was also
unable to grow utilizing citrate, isocitrate, and acetate as sole
carbon sources, all of which were utilized well by SR-11 (21).
SR-11 Fad2 grew slowly and to only one-tenth the final yield of
SR-11 utilizing pyruvate as the sole carbon source in liquid
culture (21). SR-11 Fad2 was, however, able to utilize glu-
cose, glycerol, and a number of sugars sensitive to catabolite
repression as the sole carbon sources (14). In the present
study, we identify the gene made defective in SR-11 Fad2 by
mini-Tn10::d cam transposon mutagenesis and show that the
defect is responsible for SR-11 Fad2 avirulence in BALB/c
mice.
SR-11 Fad2 is a cra (fruR) mutant. In order to identify the
gene that is inactivated in SR-11 Fad2, Southern hybridization
was performed using a digoxigenin (DIG)-labeled transposon-
specific probe made from pJHA1 (Table 1). The transposon-
specific probe was prepared with a DIG High Prime DNA
Labeling and Detection Starter Kit II (Boehringer Mannheim,
Indianapolis, Ind.) as described by the manufacturer. The
Tn10::d cam minitransposon was located on a 4.5-kb PstI
SR-11 Fad2 DNA fragment which was inserted into the unique
PstI site of pBluescript II SK(1) to create pJHA7 (Table 1).
The first 489 bp in the 4.5-kb SR-11 Fad2 insert in pJHA7 at
the T3 promoter end were sequenced. The sequence was es-
sentially identical to the last 180 bp of the serovar Typhi-
murium LT2 ilvI gene, the first 306 bp of the serovar Typhi-
murium LT2 ilvH gene, and the three intervening base pairs
(GenBank accession number X55456). The first 470 bp at the
opposite end of the 4.5-kb SR-11 Fad2 insert in pJHA7, se-
quenced from the T7 promoter, were 87% identical to yabB, a
gene of unknown function in Escherichia coli (GenBank acces-
sion number AE000118 U00096). In both serovar Typhi-
murium LT2 and E. coli, ilvI and ilvH are immediately up-
stream of the fruR gene, which is 601 bp upstream of yabB in
E. coli (GenBank accession number AE000118 U00096). Se-
quencing from the chloramphenicol resistance gene in pJHA7
determined that the mini-Tn10::d cam transposon was indeed
inserted 45 bp upstream of the 39 end of the LT2 fruR gene
(reference 9 and GenBank accession number X55456). The
fruR gene has recently been renamed cra (catabolite repressor/
activator) (18). A diagram of the genes present in the 4.5-kb
PstI SR-11 Fad2 DNA fragment in pJHA7 and the portions
sequenced is presented in Fig. 1.
Serovar Typhimurium LJ2443, a known cra mutant (3), is
unable to grow on minimal agar plates containing gluconeo-
genic substrates as sole carbon sources (3, 18). Its phenotype
with respect to utilization of different carbon sources was com-
pared to SR-11 Fad2. Both mutants were essentially identical
with respect to growth on M9 minimal agar plates containing
either sodium oleate (5 mM), sodium citrate (0.2% [wt/wt]),
potassium acetate (0.4% [wt/wt]), sodium pyruvate (0.4% [wt/
wt]), sodium succinate (0.6% [wt/wt]), potassium fumarate
(0.4% [wt/wt]), glucose (0.2% [wt/wt]), or glycerol (0.2% [wt/
wt]), i.e., they failed to grow on the gluconeogenic substrates as
sole carbon sources in 48 h at 37°C but grew as well as their
wild-type parents on glucose and glycerol. The wild-type SR-11
cra gene was cloned into pBR322 to create pJHA8 (Table 1).
Both SR-11 Fad2 and LJ2443, when complemented with
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pJHA8, regained the ability to grow on M9 agar plates con-
taining the aforementioned gluconeogenic substrates as sole
carbon sources. pBR322 did not functionally complement the
cra mutation in either SR-11 or LJ2443. These experiments
established conclusively that serovar Typhimurium SR-11
Fad2 is a cra mutant.
SR-11 Fad2 (pJHA8) is virulent. It was possible that inac-
tivation of the cra gene with the mini-Tn10::d cam insertion
caused a downstream effect that resulted in avirulence. We
therefore complemented SR-11 Fad2 with pJHA8, which con-
tains the wild-type SR-11 cra gene as the only nonvector gene
in pBR322, and tested its virulence.
Groups of four BALB/c mice were perorally infected with
either 3.1 3 108 CFU per mouse of SR-11 Fad2 (pBR322) or
4.3 3 108 CFU per mouse of SR-11 Fad2 (pJHA8). By 8 days
postinfection, three of the four mice infected with SR-11 Fad2
(pJHA8) had died. The fourth mouse infected with SR-11
Fad2 (pJHA8) appeared to be very sick for several days (ruf-
fled fur, loss of appetite, huddled) but recovered. In contrast,
the four mice infected with SR-11 Fad2 (pBR322) remained
alive and healthy. Since complementing SR-11 Fad2 with the
wild-type cra gene results in renewed virulence, it is the defect
in the cra gene caused by the mini-Tn10::d cam insertion that
renders the strain avirulent.
A serovar Typhimurium UK-1 cra mutant constructed by
allelic exchange is avirulent. It was of interest to determine
whether a cra mutant of a second serovar Typhimurium strain
was also avirulent. Therefore, a cra mutant of the virulent
strain serovar Typhimurium UK-1 (23), designated UK-1 Fad2
AX-1 (allelic exchange), was constructed by allelic exchange of
the wild-type cra gene with the mutant cra gene using pMJN10
(see Table 1). pMJN10 contains the mutant cra gene and
flanking sequences as a 4.5-kb PstI DNA fragment (Fig. 1) in
pLD55, an allelic exchange vector (15). That the only cra gene
that UK-1 Fad2 AX-1 contained was the defective cra gene
was shown by four lines of evidence. First, UK-1 Fad2 AX-1
was unable to grow on any of the gluconeogenic substrates.
Second, complementing UK-1 Fad2 AX-1 with the wild-type
cra gene returned its ability to grow on the gluconeogenic
substrates. Third, when PstI-cut UK-1 Fad2 AX-1 DNA was
probed with either the wild-type cra gene or the chloramphen-
icol resistance gene in Southern hybridization experiments, a
single 4.5-kb band was detected, as expected if the 3.1-kb PstI
DNA fragment containing the wild-type cra gene was replaced
with the defective cra gene (not shown). Fourth, when UK-1
and UK-1 AX-1 DNA were amplified by PCR using the for-
ward and reverse primers used to amplify the SR-11 wild-type
cra gene (see Fig. 1 and the legend to Fig. 2), the amplified
fragments were as expected (Fig. 2), i.e., in UK-1 a 1.4-kb
fragment containing the wild-type cra gene and in UK-1 Fad2
AX-1 a 2.8-kb fragment (the 1.4-kb cra fragment containing
the inserted 1.4-kb chloramphenicol resistance gene).
To determine whether UK-1 Fad2 AX-1 is avirulent, four
BALB/c mice were infected perorally with UK-1 (2.6 3 108
CFU per mouse), and four mice were identically infected with
UK-1 Fad2 AX-2 (1.8 3 108 CFU per mouse). By day 8
postinfection, all four UK-1 infected mice had died, whereas
the four mice infected with UK-1 AX-1 were healthy and active
and had never appeared to be sick. The UK-1 Fad2 AX-1-
infected mice were still healthy and active when the experiment
was terminated at 3 weeks postinfection. Therefore, avirulence
caused by a defect in cra is not restricted to SR-11.
SR-11 Fad2 AX-2 was also constructed by allelic exchange
of the wild-type cra gene with the mutant cra gene using
pMJN10 (see Table 1). SR-11 Fad2 AX-2 had the phenotype
of a cra mutant with respect to utilization of carbon sources.
Moreover, SR-11 Fad2 AX-2 regained the wild-type pheno-
type, when complemented with the wild-type cra gene, and
FIG. 1. Genes present in the SR-11 Fad2 4.5-kb PstI DNA fragment that
contains the chloramphenicol resistance gene (cam). Heavy lines below the genes
denote regions in the fragment that were sequenced. Sequencing reactions were
performed with the BigDye Terminator Cycle Sequencing Kit, and reactions
were analyzed on the ABI PRISM 310 (PE Applied Biosystems, Forest City,
Calif.). Nucleotide sequences were analyzed using Clone Manager and Align
Plus 3 programs (Sci-Ed Software, Durham, N.C.). Arrows above the genes
denote the direction of transcription. Arrows below the genes denote the posi-
tions of the forward and reverse primers used for PCR amplification of the
wild-type and defective cra genes. P, PstI.
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant genotype and/or phenotype Source or reference
S. enterica serovar Typhimurium
strains (plasmid)
SR-11 gyr1816 4
SR-11 Fad2 gyr1816 cra::Tn10 d cam 21
SR-11 Fad2 AX-2 gyr1816 cra::Tn10 d cam This study
SR-11 Fad2(pBR322) gyr1816 cra::Tn10 d cam, bla tet This study
SR-11 Fad2(pJHA8) gyr1816 cra::Tn10 d cam, cra1 tet This study
LJ2443 fruR51::Tn10 3
UK-1 Virulent avian strain 5
UK-1 Fad2 AX-1 cra::Tn10 d cam This study
E. coli S-17 l pir Host for pLD55 and pMJN10 V. de Lorenzo
Plasmids
pBR322 bla tet 2
pJHA1 1.4-kb cam gene from Tn10::d cam in BamHI site of pBR322 This study
pJHA7 4.3-kb PstI fragment containing cra::Tn10 d cam in pBR322, cam tet This study
pJHA8 1.4-kb cra1 gene in PstI site of pBR322, tet This study
pLD55 Suicide vector for allelic exchange, bla tetAR 15
pMJN10 4.3-kb PstI fragment containing cra::Tn10 d cam in pLD55, cat bla tetAR This study
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contained the chloramphenicol resistance gene on a 4.5-kb PstI
fragment, and the expected 2.8-kb PCR product was amplified
from SR-11 Fad2 AX-2 using the forward and reverse primers
specific to the SR-11 wild-type cra gene (Fig. 2). SR-11 Fad2
AX-2 was also found to be avirulent. Four BALB/c mice were
infected perorally with SR-11 (2.1 3 108 CFU per mouse), and
five mice were identically infected with SR-11 Fad2 AX-2
(2.8 3 108 CFU per mouse). By day 8 postinfection, all four
SR-11 infected mice had died, whereas the five mice infected
with SR-11 Fad2 AX-2 were healthy and active and had never
appeared to be sick. The SR-11 Fad2 AX-2-infected mice were
still healthy and active when the experiment was terminated at
3 weeks postinfection.
Behavior of SR-11 and SR-11 Fad2 in infection models.
Serovar Typhimurium utilizes nutrients present in intestinal
mucus for growth in the intestine (12, 14). Mammalian intes-
tinal mucus contains several sugars that SR-11 and SR-11
Fad2 could metabolize via glycolytic pathways, including N-
acetylglucosamine, N-acetylgalactosamine, galactose, fucose,
sialic acid, ribose, arabinose, mannose, gluconate, and the
hexuronates glucoronate and galacturonate (1, 17, 20). Since
serovar Typhimurium SR-11 Fad2 is not defective in its ability
to utilize sugars for growth (21), it is unlikely that it is defective
in the ability to grow in the mouse intestine. In support of this
view, in a previous study (8), when SR-11 and SR-11 Fad2
were inoculated (4.0 3 104 CFU/ml) into mouse intestinal
mucus in vitro, they grew equally well, reaching levels of about
6.0 3 108 CFU/ml in 24 h at 37°C. For this reason, we turned
our attention to the ability of SR-11 Fad2 to adhere to and
invade intestinal epithelial cells and to survive within macro-
phages.
S. enterica serovar Typhimurium passes through the epithe-
lium by penetrating and destroying the M cells of the Peyer’s
patches (10). Both SR-11 and SR-11 Fad2 invaded BALB/c
mouse M cells equally well after infection of ileal loops, made
as described previously (10), and both were found in enclosed
vacuoles within the M cells. In addition, differences were not
found in the ability of SR-11 and SR-11 Fad2 to adhere to and
invade human T-84 intestinal epithelial monolayers using pro-
cedures described previously (13), i.e., 2.41 6 0.74% (mean 6
the standard deviation [SD] of triplicate samples) of the SR-11
inoculum (20 CFU per T84 cell) and 2.06 6 0.50% of the
SR-11 Fad2 inoculum (20 CFU per T84 cell) became cell
associated in 60 min. In the same time, 0.094 6 0.009% of the
SR-11 inoculum and 0.089 6 0.016% of the SR-11 Fad2 in-
oculum were internalized. Collectively, these results make it
unlikely that SR-11 Fad2 is avirulent because it is defective in
its ability to adhere to and invade M cells and/or intestinal
epithelial cells.
The ability to survive in macrophages in vitro has been
correlated with S. enterica pathogenicity in mice (7, 16). Res-
ident peritoneal macrophages were isolated from BALB/c
mice (7), and survival of SR-11 and SR-11 Fad2 in macro-
phages was determined as described previously (7). Both
SR-11 and SR-11 Fad2 survived equally well in resident peri-
toneal macrophages. That is, after 60 min 0.057 6 0.0075%
(mean 6 the SD of triplicate samples) of the SR-11 inoculum
and 0.056 6 0.018% of the SR-11 Fad2 inoculum survived and,
in each case, both strains remained at the 1-h survival level for
the next 23 h. While these data rule out the possibility that
SR-11 Fad2 is inherently inferior to SR-11 in surviving in
BALB/c peritoneal macrophages, they do not rule out the
possibility that SR-11 Fad2 is avirulent because its ability to
survive and grow in macrophages in vivo is decreased relative
to that of SR-11. Serovar Typhimurium may, in fact, utilize
gluconeogenic substrates for survival and growth in macro-
phages in vivo (e.g., succinate, pyruvate, etc.). If so, SR-11
Fad2 would be at a distinct disadvantage. In the present ex-
periments, the BALB/c resident peritoneal macrophages were
continuously bathed in RPMI 1640 medium. RPMI 1640 me-
dium contains 2 g of glucose per liter which SR-11 and SR-11
Fad2 metabolize equally well.
In summary, a functional cra gene is necessary for serovar
Typhimurium virulence in BALB/c mice. The Cra protein is a
regulator of central carbon metabolism (18). When interacting
with the genes it regulates, i.e., in the presence of gluconeo-
genic substrates (18), the Cra protein positively regulates tran-
scription of those genes encoding biosynthetic and oxidative
enzymes (e.g., key enzymes in the tricarboxylic acid cycle, the
glyoxylate bypass, the gluconeogenic pathway, and electron
transport) and negatively regulates transcription of genes en-
coding glycolytic enzymes, e.g., key enzymes in the Embden-
Meyerhof and Entner-Doudoroff pathways (18). Since in a cra
mutant the genes involved in glycolytic pathways are highly
expressed, whereas the expression of genes involved in the
gluconeogenic pathway and the glyoxylate bypass is reduced, it
is possible that gluconeogenesis is required for serovar Typhi-
murium virulence. In support of this view, it has recently been
reported that a MudJ insertion in a putative malate oxi-
doreductase gene, involved in gluconeogenesis, renders sero-
var Typhimurium avirulent and immunogenic (22). Since
SR-11 Fad2 grows as well as SR-11 in intestinal mucus (8),
FIG. 2. PCR amplification of the defective cra genes of serovar Typhimurium
SR-11 Fad2, SR-11 Fad2 AX-2, and UK-1 Fad2 AX-1. Genomic DNA prepa-
rations were performed by standard techniques (13) or by following the manu-
facturer’s instructions. Genomic DNA preparations of SR-11, SR-11 Fad2,
SR-11 Fad2 AX-2, UK-1, and UK-1 AX-1 were amplified by PCR using 59-AT
CGACTGCAGTGCGAAATCCGTGGTAACCCGG-39 as the forward primer
and 59-TAGCTCTGCAGCCTGTTTAACGTGTGCGGTGCC-39 as the reverse
primer. PCR reaction mixtures contained 2.0 mM magnesium chloride and 5%
dimethyl sulfoxide and were subjected to 25 cycles of 94°C for 30 s, followed by
65°C for 30 s, followed by 72°C for 2.5 min. Lane 1, kilobase ladder; lane 2, SR-11
Fad2 AX-2; lane 3, SR-11 Fad2; lane 4, SR-11; lane 5, UK-1 Fad2 AX-1; lane
6, UK-1; lane 7, no DNA added; lane 8, kilobase ladder.
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enters M cells as well as SR-11 in vivo, and adheres to epithe-
lial cells as well as SR-11 in vitro, it is unlikely that SR-11 Fad2
is avirulent because it is either defective in its ability to grow in
the intestine or defective in its ability to adhere to and enter
intestinal epithelial cells and M cells in vivo. If, however, the
only available carbon sources for S. enterica serovar Typhi-
murium survival and growth in M cells and/or in macrophages
in vivo are the gluconeogenic substrates, since SR-11 Fad2
would be unable to grow under these conditions, it would not
be surprising if this were the reason for its avirulence in mice.
In situ experiments will be required to test this hypothesis.
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